Clinical trial

Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study

NCT03919253

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-04-30

PhasePHASE2

Study timeline

Study start (estimated)2019-04-30Date precision: day

Registry last updated2019-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HER2-positive Breast Cancerunresolved

Interventions

pyrotinib maleate tablets+nab-paclitaxelCOMBINATION_PRODUCT

Sponsors & collaborators

Hebei Medical University Fourth Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03919253 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.